Paul Brian Dieffenbach, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Matrix Metalloproteinase 8 | 1 | 2021 | 56 | 0.790 |
Why?
|
| Pulmonary Artery | 5 | 2024 | 1910 | 0.580 |
Why?
|
| Airway Remodeling | 1 | 2017 | 133 | 0.530 |
Why?
|
| Myocytes, Smooth Muscle | 3 | 2024 | 684 | 0.500 |
Why?
|
| Cyclooxygenase 2 | 1 | 2017 | 600 | 0.480 |
Why?
|
| Hypertension, Pulmonary | 6 | 2024 | 1567 | 0.430 |
Why?
|
| Vascular Diseases | 1 | 2021 | 1178 | 0.420 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2017 | 1125 | 0.410 |
Why?
|
| Phosphoproteins | 2 | 2018 | 2441 | 0.390 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2018 | 2897 | 0.350 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2017 | 2867 | 0.310 |
Why?
|
| I-kappa B Kinase | 1 | 2024 | 251 | 0.210 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2021 | 8147 | 0.210 |
Why?
|
| Extracellular Matrix | 3 | 2022 | 1725 | 0.190 |
Why?
|
| Neuromuscular Blocking Agents | 1 | 2022 | 130 | 0.180 |
Why?
|
| Neuromuscular Blockade | 1 | 2022 | 146 | 0.180 |
Why?
|
| Biophysics | 1 | 2021 | 380 | 0.180 |
Why?
|
| Ammonium Chloride | 1 | 2019 | 72 | 0.170 |
Why?
|
| Acetazolamide | 1 | 2019 | 97 | 0.170 |
Why?
|
| Carbonic Anhydrase Inhibitors | 1 | 2019 | 91 | 0.160 |
Why?
|
| Carbonic Anhydrases | 1 | 2019 | 109 | 0.160 |
Why?
|
| Collagen Type III | 1 | 2018 | 91 | 0.150 |
Why?
|
| Respiratory Therapy | 1 | 2018 | 127 | 0.150 |
Why?
|
| Thorax | 1 | 2019 | 553 | 0.140 |
Why?
|
| Anesthetics | 1 | 2022 | 523 | 0.130 |
Why?
|
| Administration, Inhalation | 1 | 2018 | 1154 | 0.130 |
Why?
|
| Carbon Monoxide | 1 | 2018 | 541 | 0.130 |
Why?
|
| Tuberous Sclerosis | 1 | 2022 | 1030 | 0.120 |
Why?
|
| Up-Regulation | 3 | 2021 | 4123 | 0.120 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 3793 | 0.120 |
Why?
|
| Lung | 4 | 2021 | 9980 | 0.120 |
Why?
|
| Rats | 5 | 2024 | 23577 | 0.120 |
Why?
|
| Feedback, Physiological | 1 | 2015 | 476 | 0.110 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 1618 | 0.100 |
Why?
|
| Demography | 1 | 2017 | 1648 | 0.100 |
Why?
|
| Fibrosis | 1 | 2018 | 2038 | 0.090 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 1994 | 0.090 |
Why?
|
| Anesthesia | 1 | 2022 | 1580 | 0.090 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2015 | 530 | 0.090 |
Why?
|
| Homeostasis | 1 | 2020 | 3301 | 0.080 |
Why?
|
| Respiration, Artificial | 2 | 2019 | 2617 | 0.080 |
Why?
|
| Epithelial Cells | 1 | 2020 | 3664 | 0.080 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2017 | 898 | 0.080 |
Why?
|
| Trans-Activators | 1 | 2017 | 2857 | 0.070 |
Why?
|
| Transcription Factors | 2 | 2017 | 12106 | 0.070 |
Why?
|
| Critical Illness | 1 | 2019 | 2703 | 0.070 |
Why?
|
| Animals | 10 | 2024 | 167531 | 0.070 |
Why?
|
| Mice, Knockout | 1 | 2021 | 14333 | 0.070 |
Why?
|
| Cell Proliferation | 2 | 2022 | 10427 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 21892 | 0.060 |
Why?
|
| Sulfur Radioisotopes | 2 | 2003 | 113 | 0.060 |
Why?
|
| Cell Movement | 1 | 2017 | 5196 | 0.060 |
Why?
|
| Sepsis | 1 | 2018 | 2593 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2021 | 21992 | 0.060 |
Why?
|
| Beta Particles | 1 | 2003 | 47 | 0.060 |
Why?
|
| Inflammation | 2 | 2020 | 10746 | 0.060 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2005 | 485 | 0.050 |
Why?
|
| Mice | 5 | 2022 | 80993 | 0.050 |
Why?
|
| Methionine | 2 | 2003 | 569 | 0.050 |
Why?
|
| Aging | 1 | 2021 | 8633 | 0.050 |
Why?
|
| DNA Fragmentation | 1 | 2001 | 237 | 0.050 |
Why?
|
| Humans | 15 | 2024 | 759098 | 0.050 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2019 | 5628 | 0.040 |
Why?
|
| Middle Aged | 5 | 2021 | 219628 | 0.040 |
Why?
|
| Adult | 5 | 2021 | 219353 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2015 | 3797 | 0.040 |
Why?
|
| Phenotype | 1 | 2017 | 16524 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2017 | 23328 | 0.040 |
Why?
|
| APACHE | 1 | 2019 | 267 | 0.040 |
Why?
|
| Carboxyhemoglobin | 1 | 2018 | 80 | 0.040 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2020 | 271 | 0.040 |
Why?
|
| Contractile Proteins | 1 | 2019 | 240 | 0.040 |
Why?
|
| Male | 7 | 2021 | 358602 | 0.040 |
Why?
|
| Dopamine | 1 | 2005 | 1582 | 0.040 |
Why?
|
| Smad3 Protein | 1 | 2018 | 168 | 0.040 |
Why?
|
| Blood Gas Analysis | 1 | 2018 | 378 | 0.040 |
Why?
|
| Acidosis | 1 | 2019 | 271 | 0.040 |
Why?
|
| Macrophages, Alveolar | 1 | 2019 | 410 | 0.040 |
Why?
|
| Female | 6 | 2021 | 390174 | 0.030 |
Why?
|
| LDL-Receptor Related Proteins | 1 | 2015 | 118 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2019 | 1695 | 0.030 |
Why?
|
| Systems Biology | 1 | 2018 | 479 | 0.030 |
Why?
|
| Organ Size | 1 | 2019 | 2247 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2019 | 1343 | 0.030 |
Why?
|
| Aged | 3 | 2021 | 168615 | 0.030 |
Why?
|
| DNA, Mitochondrial | 1 | 2018 | 849 | 0.030 |
Why?
|
| DNA Damage | 1 | 2003 | 2442 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2001 | 2134 | 0.030 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2019 | 1481 | 0.030 |
Why?
|
| PPAR gamma | 1 | 2015 | 484 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2015 | 2511 | 0.020 |
Why?
|
| Gene Expression | 1 | 2003 | 7583 | 0.020 |
Why?
|
| Apolipoproteins E | 1 | 2015 | 1436 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2020 | 3105 | 0.020 |
Why?
|
| Protein Binding | 1 | 2018 | 9334 | 0.020 |
Why?
|
| Length of Stay | 1 | 2019 | 6452 | 0.020 |
Why?
|
| Depression | 1 | 2005 | 8026 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2019 | 5414 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2018 | 3534 | 0.020 |
Why?
|
| Calmodulin | 1 | 2005 | 217 | 0.010 |
Why?
|
| Macrophages | 1 | 2019 | 5723 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2019 | 12765 | 0.010 |
Why?
|
| Massachusetts | 1 | 2017 | 8788 | 0.010 |
Why?
|
| Radioactive Tracers | 1 | 2003 | 66 | 0.010 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2005 | 490 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2005 | 929 | 0.010 |
Why?
|
| Registries | 1 | 2019 | 8435 | 0.010 |
Why?
|
| CDC2 Protein Kinase | 1 | 2003 | 213 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2005 | 1757 | 0.010 |
Why?
|
| Gamma Rays | 1 | 2003 | 316 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2019 | 11461 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2003 | 2925 | 0.010 |
Why?
|
| Asthma | 1 | 2020 | 6159 | 0.010 |
Why?
|
| Thymidine | 1 | 2001 | 300 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 2005 | 1456 | 0.010 |
Why?
|
| Tritium | 1 | 2001 | 707 | 0.010 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2001 | 878 | 0.010 |
Why?
|
| Corpus Striatum | 1 | 2005 | 1232 | 0.010 |
Why?
|
| Cell Hypoxia | 1 | 2001 | 657 | 0.010 |
Why?
|
| Cells, Cultured | 2 | 2005 | 18937 | 0.010 |
Why?
|
| Gene Silencing | 1 | 2003 | 1512 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2003 | 2698 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2003 | 6132 | 0.010 |
Why?
|
| Kinetics | 1 | 2003 | 6373 | 0.010 |
Why?
|
| Rabbits | 1 | 2001 | 4772 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2003 | 3772 | 0.010 |
Why?
|
| Radiation Dosage | 1 | 2003 | 1955 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2017 | 41266 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2005 | 13439 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2019 | 64867 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2005 | 17611 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2017 | 54190 | 0.010 |
Why?
|
| Calcium | 1 | 2005 | 5718 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2019 | 80125 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2003 | 9372 | 0.000 |
Why?
|
| Neurons | 1 | 2005 | 9410 | 0.000 |
Why?
|
| Mutation | 1 | 2005 | 29878 | 0.000 |
Why?
|
| Time Factors | 1 | 2001 | 40083 | 0.000 |
Why?
|